CrushSCI.com
159.7Average days
161Median days
18Fastest days
344Longest days
712025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

136 days

Impact of chronic obstructive pulmonary disease on survival after chimeric antigen receptor T-cell therapy in large B-cell lymphoma

Authors
Mehmet S. Uyanik; Athanasios Tsalatsanis; Ibrahim Muhsen; Aditi Saha; Mahmoud Aljurf; Hong Qin; Julio C. Chavez; Ambuj Kumar; Mohamed A. Kharfan-DabajaShow moreShow less
Affiliations
Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA; Research Methodology and Biostatistics Core, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Division of Hematology-Oncology and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA; King Faisal Specialist Hospital & Research Centre, Adult Stem Cell Transplantation and Cellular Therapy Program, Riyadh, Saudi ArabiaShow moreShow less
Source PDF DOI Publisher page
172 days

Post-transplant lineage transformation to blastic plasmacytoid dendritic cell neoplasm in advanced systemic mastocytosis with associated CMML: a case report

Authors
Omar Khaled; Alexander Woodman; Camron Farjami; Zachary Goldstein; Eric Leon Tam; Karrune Woan; Preet Chaudhary; Amir Ali; Imran S Siddiqi; George YaghmourShow moreShow less
Affiliations
Keck School of Medicine, University of Southern California, Los Angeles, California, USA; Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Norris Comprehensive Cancer Center, Los Angeles, California, USA; Department of Dermatopathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA; Department of Pharmacy, University of Southern California, Norris Comprehensive Cancer Center, California, Los Angeles, USA; Division of Pathology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California, USAShow moreShow less
Source PDF DOI Publisher page
161 days

A shared-care model for autologous transplantation: Feasibility and optimization of tertiary center resources

Authors
Ana Jiménez-Ubieto; Adolfo Jesús Sáez Marín; Paula Lázaro; José María Sánchez Pina; Rodrigo Iñiguez García; Magdalena Corona; Rafael Alonso; Laura Montejano; Pilar Martínez-Sánchez; Daniel Gil-Alos; Nieves López; Guillermo Ramos; Pilar Bravo; María Stefania Infante; José-Ángel Hernández-Rivas; Juan Churruca; Renata García-Gigorro; Iryna Luts; Fernando Solano; Jacobo Galán Vega; Joaquín Martínez-López; Juan José Lahuerta; M. CalbachoShow moreShow less
Affiliations
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain; Imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain; Department of Hematology, Hospital Universitario La Paz, Madrid, Spain; Department of Hematology, Hospital Universitario de Fuenlabrada, Madrid, Spain; Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Intensive Care, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Hematology, Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, SpainShow moreShow less
Source PDF DOI Publisher page
344 days

Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line

Authors
Atefeh Habibi Asl; Reza Valadan; Saeid Taghiloo; Nazanin Joudaki; Hossein Asgarian-Omran; Ehsan Zaboli; Mahdieh Darvishkhezri; Abolghasem AjamiShow moreShow less
Affiliations
Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Immunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran; Department of Infectious Diseases, Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, IranShow moreShow less
Source PDF DOI Publisher page
18 days

Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts

Authors
Alexis Cuffel; Aurélie Bisson; Philippe Ruminy; Vinciane Rainville; Justine Dehayes; Arnaud Fleury; Clara Blondel; Maud Maho-Vaillant; Catherine Boutet; Véronique Saada; Célia Lobrano; Camille Giverne; Jérémie Martinet; Olivier Boyer; Jean-Baptiste LatoucheShow moreShow less
Affiliations
CHU de Rouen, Laboratoire d’Immunologie et de Biothérapies, Université de Rouen Normandie, Inserm, UMR 1234, F-76000 Rouen, France; Université de Rouen Normandie, Inserm, UMR 1245, Centre Henri Becquerel, Rouen, France; CHU de Rouen, Laboratoire d’Hématologie, F-76000 Rouen, France; Institut Gustave Roussy, Département de Biologie et Pathologie médicales, Université Paris-Saclay, F-94805, Villejuif, France; CHU Lille, Univ. Lille, Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000 Lille, FranceShow moreShow less
Source PDF DOI Publisher page
184 days

Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients

Authors
Ali Ahadzade; Tugrul Elverdi; Selin Kucukyurt; Abdulkadir Ercaliskan; Tuba Ozkan; Ahu Senem Demiröz; Deniz Ozmen; Umut Yılmaz; Ahmet Emre Eskazan; Muhlis Cem Ar; Yıldız Aydın; Ayse SalihogluShow moreShow less
Affiliations
Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey; Department of Pathology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, TurkeyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Current Research in Translational Medicine take to review a manuscript?

As of 2026-11-14, CrushSCI has 15 complete review records for Current Research in Translational Medicine. The fastest paper went from submission to acceptance in 18 days (Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts, received 2026-08-27, accepted 2026-09-14); the slowest took 344 days. The average is 159.7 days and the median is 161 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.